FASN and breast cancer: The potential of neutraceuticals such as green tea polyphenol epigallocatechin-3-gallate (EGCG) and other flavonoids against breast cancer through downregulating the FASN activity has been suggested by previous studies (Pan et al., 2007; Puig et al., 2008; Khan et al., 2014).